Tardyferon 80 mg Iron Supplement

Tardyferon is a widely recognized medicinal supplement used primarily for the treatment and prevention of iron deficiency and iron deficiency anemia. The brand was developed in France by Pierre Fabre Laboratories, a multinational pharmaceutical and cosmetics company founded in 1962 by pharmacist Pierre Fabre.

Manufacturing of Tardyferon is centrally located in France, specifically at the Pierre Fabre Medicament production sites. The brand remains under the ultimate ownership of the Pierre Fabre Group, which is uniquely structured as it is predominantly owned by the Pierre Fabre Foundation, a government-recognized public interest foundation. This ownership model ensures that the company's profits are reinvested into healthcare initiatives and drug development rather than private shareholders.